HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

15d-prostaglandin J2 protects brain from ischemia-reperfusion injury.

AbstractOBJECTIVE:
Brain expresses abundant lipocalin-type prostaglandin (PG) D2 (PGD2) synthase but the role of PGD2 and its metabolite, 15-deoxy-Delta(12,14) PGJ2 (15d-PGJ2) in brain protection is unclear. The aim of this study is to assess the effect of 15d-PGJ2 on neuroprotection.
METHODS AND RESULTS:
Adenoviral transfer of cyclooxygenase-1 (Adv-COX-1) was used to amplify the production of 15d-PGJ2 in ischemic cortex in a rat focal infarction model. Cortical 15d-PGJ2 in Adv-COX-1-treated rats was increased by 3-fold over control, which was correlated with reduced infarct volume and activated caspase 3, and increased peroxisome proliferator activated receptor-gamma (PPARgamma) and heme oxygenase-1 (HO-1). Intraventricular infusion of 15d-PGJ2 resulted in reduction of infarct volume, which was abrogated by a PPARgamma inhibitor. Rosiglitazone infusion had a similar effect. 15d-PGJ2 and rosiglitazone at low concentrations suppressed H2O2-induced rat or human neuronal apoptosis and necrosis and induced PPARgamma and HO-1 expression. The anti-apoptotic effect was abrogated by PPARgamma inhibition.
CONCLUSIONS:
15d-PGJ2 suppressed ischemic brain infarction and neuronal apoptosis and necrosis in a PPARgamma dependent manner. 15d-PGJ2 may play a role in controlling acute brain damage induced by ischemia-reperfusion.
AuthorsTeng-Nan Lin, Wai-Mui Cheung, Jui-Sheng Wu, Jean-Ju Chen, Heng Lin, Jin-Jer Chen, Jun-Yang Liou, Song-Kun Shyue, Kenneth K Wu
JournalArteriosclerosis, thrombosis, and vascular biology (Arterioscler Thromb Vasc Biol) Vol. 26 Issue 3 Pg. 481-7 (Mar 2006) ISSN: 1524-4636 [Electronic] United States
PMID16385084 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • 15-deoxyprostaglandin J2
  • Neuroprotective Agents
  • PPAR gamma
  • Thiazolidinediones
  • Vasodilator Agents
  • Rosiglitazone
  • Heme Oxygenase-1
  • Cyclooxygenase 1
  • CASP3 protein, human
  • Casp3 protein, rat
  • Caspase 3
  • Caspases
  • Prostaglandin D2
Topics
  • Adenoviridae (genetics)
  • Animals
  • Apoptosis (drug effects, physiology)
  • Caspase 3
  • Caspases (metabolism)
  • Cells, Cultured
  • Cyclooxygenase 1 (genetics, metabolism)
  • Gene Transfer Techniques
  • Genetic Therapy
  • Heme Oxygenase-1 (genetics, metabolism)
  • Infarction, Middle Cerebral Artery (metabolism, therapy)
  • Male
  • Necrosis
  • Neurons (pathology)
  • Neuroprotective Agents (metabolism)
  • PPAR gamma (genetics, metabolism)
  • Prostaglandin D2 (analogs & derivatives, metabolism)
  • Rats
  • Rats, Long-Evans
  • Reperfusion Injury (metabolism, prevention & control, therapy)
  • Rosiglitazone
  • Thiazolidinediones (pharmacology)
  • Vasodilator Agents (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: